Investors & Media

Corporate Profile

Investor Relations

Corporate Profile


Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Engage with us on FacebookLinkedInInstagram, and X.

Contact us for investor and media inquiries.


Data Provided by Refinitiv. Minimum 15 minutes delayed.

Sage Therapeutics Intra Stock Chart